In response to increasing rates of sudden cardiac death caused by heart attacks, the Karnataka government will soon make it mandatory for every employee working in the corporate and private sectors to get a health checkup annually
The death toll at the Telangana factory blast at Sigachi Industries has reached 44 making it one of the most tragic industrial calamities in the state. The incident occurred on June 30, at the company's manufacturing plant at Pashamylaram in the...
Kerala has declared a health alert in three districts, Kozhikode, Malappuram, and Palakkad, in view of two suspected cases of the Nipah virus. The Health department of Kerala made a note of the two patients who presented with Nipah-like symptoms...
Amid renewed public discussions about vaccine safety, the Serum Institute of India (SII) and Indian Vaccine Manufacturers Association (IVMA) pointedly reiterated that COVID-19 vaccines are safe, efficacious and scientifically verified...
In a recent response to the reports in Karnataka's Hassan district claiming COVID-19 vaccines led to heart attack deaths, the Indian Pharmaceutical Alliance (IPA) expressed its strong defense of both vaccine safety and the integrity of regulatory...
In a major development for India's drug regulatory system, the Delhi High Court has ordered the Drug Controller General of India (DCGI) to respond within three months to a Public Interest Litigation (PIL) that challenges the approval of...
In a major decision to enhance the food safety standards, the Food Safety and Standards Authority of India (FSSAI) has ordered a "100 per cent inspection" of all packaged drinking water units in Maharashtra.
Glenmark Pharmaceuticals announced on Wednesday that the US FDA issued a Form 483 with five procedural observations after an inspection of its Monroe Manufacturing Facility in North Carolina...
.jpeg)
Syngene International shares are expected to be in focus after two major regulatory statements by the United States Food and Drug Administration (USFDA) on inspections at the company's Bengaluru-based facilities.
.jpeg)
The alarming surge in fake medicines detected across multiple Indian states has stimulated drug regulators to push for immediate, forceful intervention to protect public health and restore trust in the country’s pharmaceutical ecosystem.
.jpg)
.jpg)
, CDSCO.jpg)